Management of HBV reactivation in non-oncological patients-Reference-Cited by-同舟云学术

Management of HBV reactivation in non-oncological patients

Published:2018-08-03 Issue:8 Volume:16 Page:611-624
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Pisaturo Mariantonietta¹,Di Caprio Giovanni¹,Calò Federica¹,Portunato Federica¹,Martini Salvatore¹²,Coppola Nicola¹³

Affiliation:

1. Department of Mental Health and Public Medicine, Section of Infectious Diseases, University of Campania, Naples, Italy

2. Section of Infectio us Diseases, A.O.R.N. Dei Colli, Cotugno Hospital, Napoli, Italy

3. Section of Infectious Diseases, A.O.R.N S.Anna S. Sebastiano Caserta, Caserta, Italy

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2018.1505501

Reference98 articles.

1. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors

2. Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings

3. Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

4. World Health Organization [Internet]. Geneva: World Health Organization. 2017 Jul. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/

5. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COL15A1 interacts with P4HB to regulate the growth and malignancy of HepG2.2.15 cells;Biochemical and Biophysical Research Communications;2023-11

2. Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment;World Journal of Virology;2022-09-25

3. Tenofovir alafenamid prophylaxis for the prevention of HBV reactivation in immunosuppressed subjects: a multicenter study;CUKUROVA MED J;2022

4. Research Progress of HLA and Hepatitis B Virus Infection;Advances in Clinical Medicine;2022

5. Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases;Journal of Clinical Medicine;2021-11-08